Form 4: Director Acquires TMO Phantom Stock Units via Deferred Plan

Thermo Fisher Scientific Director Scott M. Sperling acquired 73.35 phantom stock units as part of a deferred compensation plan.

Summary

• Scott M. Sperling, a Director of Thermo Fisher Scientific Inc. (TMO), acquired 73.35 phantom stock units.
• The acquisition occurred as of December 31, 2025, at a price of $579.45 per unit.
• These units were credited to Sperling's account under the Issuer's Deferred Compensation Plan for Directors.
• Directors' retainers are deferred quarterly into Common Stock units based on the closing price at quarter-end.
• The phantom stock units are convertible into Common Stock on a 1-for-1 basis.
• Following this transaction, Sperling beneficially owns 17,502.02 phantom stock units.
• The shares are distributable as stock upon cessation of director service or a change of control.

Sentiment

Score: 7

Explanation: The transaction is a positive indicator of director alignment with shareholder interests through equity ownership, albeit a routine compensation event rather than a discretionary open-market purchase.

Positives

• Director Scott M. Sperling increased his beneficial ownership in the company by acquiring 73.35 phantom stock units.
• The acquisition was part of a deferred compensation plan, indicating alignment of director interests with long-term shareholder value.

Future Outlook

NA

Industry Context

This is a routine insider transaction filing for director compensation, common across publicly traded companies, reflecting standard corporate governance practices for aligning director interests with long-term company performance.

Comparison to Industry Standards

• The use of deferred compensation plans for directors, where retainers are converted into equity-based units, is a common practice among large-cap companies in the life sciences and healthcare technology sectors, including peers like Danaher Corporation and Agilent Technologies, to foster long-term alignment with shareholder interests.
• The specific terms, such as the 1-for-1 conversion of phantom units to common stock and distribution upon cessation of service, are standard for such plans.

Corporate Governance

Stakeholder Impact

• Shareholders: Increased alignment of director's financial interests with long-term company performance.

Next Steps

• Distribution of shares upon cessation of director service or a change of control.

Key Dates

Recommendation

This Form 4 reports a routine, non-discretionary acquisition of phantom stock units by a director as part of a deferred compensation plan. While it indicates continued alignment of director interests with the company, it does not represent a new investment decision or significant change in company fundamentals that would warrant a 'buy' or 'sell' recommendation. The transaction is expected and reflects standard corporate governance.

Keywords

Thermo Fisher Scientific, TMO, Scott M. Sperling, Form 4, Insider Trading, Phantom Stock Units, Deferred Compensation, Director Compensation, Beneficial Ownership